
Neuralink is a neurotechnology company founded by Elon Musk and a team of scientists and engineers in 2016.
The company is developing implantable brain-computer interfaces (BCIs) with the goal of treating serious brain diseases and eventually enhancing human capabilities.
The company has developed a “sewing machine-like” device capable of implanting very thin threads into the brain and hopes the procedure will one day be as efficient as laser eye surgery.
These threads are designed to interpret signals produced in the brain and relay information to devices via Bluetooth.
The threads are 4 to 6 μm in width, which makes them considerably thinner than a human hair.
A tiny chip connects to the brain through the threads, which are thinner than a human hair and are barely perceptible with the human eye.
Neuralink is going to tap into these tiny electric fields generated as sinus junctions in the brain.
It can interpret this analog data as ones and zeros to be used in the digital world.
The neuron pulses will be detected using tiny threads about one-tenth the cross-section of a human hair or about the size of a neuron.
In May 2023, Neuralink received approval from the US Food and Drugs Administration (FDA) to conduct its first tests on humans.
Neuralink hopes to use its microchips to treat conditions such as paralysis and blindness and to help certain disabled people use computers and mobile technology.
Experts have cautioned that Neuralink’s brain implants will require extensive testing to overcome technical and ethical challenges if they are to become widely available.
Elon Musk has also suggested that the proposed technology could help ease concerns about humans being displaced by AI.
